BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother 2007;8:1885-902. [PMID: 17696791 DOI: 10.1517/14656566.8.12.1885] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Koehler AV, Jex AR, Haydon SR, Stevens MA, Gasser RB. Giardia/giardiasis — A perspective on diagnostic and analytical tools. Biotechnology Advances 2014;32:280-9. [DOI: 10.1016/j.biotechadv.2013.10.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 7.5] [Reference Citation Analysis]
2 Mohebali M, Keshavarz H, Abbaszadeh Afshar MJ, Hanafi-Bojd AA, Hassanpour G. Spatial Distribution of Common Pathogenic Human Intestinal Protozoa in Iran: A Systematic Review. Iran J Public Health 2021;50:69-82. [PMID: 34178765 DOI: 10.18502/ijph.v50i1.5073] [Reference Citation Analysis]
3 Wang Y, Zheng G, Li Y. Giardia duodenalis GlSir2.2, homolog of SIRT1, is a nuclear-located and NAD+-dependent deacethylase. Experimental Parasitology 2016;169:28-33. [DOI: 10.1016/j.exppara.2016.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Singh G, Chowdhary K, Satija P, Singh A, Singh B, Singh K, Espinosa C, Esteban MA, Sehgal R, Verma V. Synthesis and Immobilization of Benzothiazole-Appended Triazole-Silane: Biological Evaluation and Molecular Docking Approach. ChemistrySelect 2018;3:1609-14. [DOI: 10.1002/slct.201703017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Speich B, Croll D, Fürst T, Utzinger J, Keiser J. Effect of sanitation and water treatment on intestinal protozoa infection: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:87-99. [PMID: 26404667 DOI: 10.1016/S1473-3099(15)00349-7] [Cited by in Crossref: 81] [Cited by in F6Publishing: 49] [Article Influence: 11.6] [Reference Citation Analysis]
6 Fleckenstein JM, Bartels SR, Drevets PD, Bronze MS, Drevets DA. Infectious agents of food- and water-borne illnesses. Am J Med Sci 2010;340:238-46. [PMID: 20823701 DOI: 10.1097/MAJ.0b013e3181e99893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
7 Azam A, Peerzada MN, Ahmad K. Parasitic diarrheal disease: drug development and targets. Front Microbiol 2015;6:1183. [PMID: 26617574 DOI: 10.3389/fmicb.2015.01183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Araki H, Shimizu S, Hayashi K, Yamada T, Kusakabe A, Kanie H, Mizuno Y, Kojima I, Saitou A, Nagao K, Suzuki Y, Toyohara T, Suzuki T, Uchida E, Uno K, Nakazawa T. Acute Acalculous Cholecystitis Caused by Giardia lamblia. Intern Med. 2017;56:1657-1662. [PMID: 28674353 DOI: 10.2169/internalmedicine.56.8087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
9 Ydsten KA, Hellgren U, Asgeirsson H. Quinacrine treatment of nitroimidazole-refractory giardiasis. J Infect Dis 2021:jiab287. [PMID: 34036328 DOI: 10.1093/infdis/jiab287] [Reference Citation Analysis]
10 Buchko GW, Abendroth J, Robinson H, Zhang Y, Hewitt SN, Edwards TE, Van Voorhis WC, Myler PJ. Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia. J Struct Funct Genomics 2013;14:47-57. [PMID: 23709284 DOI: 10.1007/s10969-013-9155-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Légaré D, Ouellette M. Drug Resistance Assays for Parasitic Diseases. In: Mayers DL, Sobel JD, Ouellette M, Kaye KS, Marchaim D, editors. Antimicrobial Drug Resistance. Cham: Springer International Publishing; 2017. pp. 1409-63. [DOI: 10.1007/978-3-319-47266-9_36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Amer EI, Mossallam SF, Mahrous H. Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. Exp Parasitol 2014;146:52-63. [PMID: 25300763 DOI: 10.1016/j.exppara.2014.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
13 Kalinowska-Lis U, Felczak A, Chęcińska L, Zawadzka K, Patyna E, Lisowska K, Ochocki J. Synthesis, characterization and antimicrobial activity of water-soluble silver(i) complexes of metronidazole drug and selected counter-ions. Dalton Trans 2015;44:8178-89. [PMID: 25846722 DOI: 10.1039/c5dt00403a] [Cited by in Crossref: 57] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
14 Singh G, Arora A, Mangat SS, Rani S, Kaur H, Goyal K, Sehgal R, Maurya IK, Tewari R, Choquesillo-lazarte D, Sahoo S, Kaur N. Design, synthesis and biological evaluation of chalconyl blended triazole allied organosilatranes as giardicidal and trichomonacidal agents. European Journal of Medicinal Chemistry 2016;108:287-300. [DOI: 10.1016/j.ejmech.2015.11.029] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
15 Ansell BR, McConville MJ, Baker L, Korhonen PK, Young ND, Hall RS, Rojas CA, Svärd SG, Gasser RB, Jex AR. Time-Dependent Transcriptional Changes in Axenic Giardia duodenalis Trophozoites. PLoS Negl Trop Dis 2015;9:e0004261. [PMID: 26636323 DOI: 10.1371/journal.pntd.0004261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
16 Weerakoon KG, Gordon CA, Williams GM, Cai P, Gobert GN, Olveda RM, Ross AG, Olveda DU, McManus DP. Co-parasitism of intestinal protozoa and Schistosoma japonicum in a rural community in the Philippines. Infect Dis Poverty 2018;7:121. [PMID: 30526666 DOI: 10.1186/s40249-018-0504-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
17 Escobedo AA, Alvarez G, González ME, Almirall P, Cañete R, Cimerman S, Ruiz A, Pérez R. The treatment of giardiasis in children: single-dose tinidazole compared with 3 days of nitazoxanide. Ann Trop Med Parasitol 2008;102:199-207. [PMID: 18348774 DOI: 10.1179/136485908X267894] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
18 Astiazarán-García H, Iñigo-Figueroa G, Quihui-Cota L, Anduro-Corona I. Crosstalk between Zinc Status and Giardia Infection: A New Approach. Nutrients 2015;7:4438-52. [PMID: 26046395 DOI: 10.3390/nu7064438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Cock IE, Rayan P. Ascorbic acid potentiates the Giardia duodenalis growth inhibitory activity of pure Terminalia ferdinandiana Exell compounds. Parasitol Res 2020;119:1125-37. [PMID: 31907666 DOI: 10.1007/s00436-019-06579-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Watkins RR, Eckmann L. Treatment of giardiasis: current status and future directions. Curr Infect Dis Rep 2014;16:396. [PMID: 24493628 DOI: 10.1007/s11908-014-0396-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
21 Conners EE, Miller AD, Balachandran N, Robinson BM, Benedict KM. Giardiasis Outbreaks - United States, 2012-2017. MMWR Morb Mortal Wkly Rep 2021;70:304-7. [PMID: 33661866 DOI: 10.15585/mmwr.mm7009a2] [Reference Citation Analysis]
22 Escobedo AA, Hanevik K, Almirall P, Cimerman S, Alfonso M. Management of chronic Giardia infection. Expert Rev Anti Infect Ther 2014;12:1143-57. [PMID: 25059638 DOI: 10.1586/14787210.2014.942283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
23 Peters TE, Kreuels B, Addo MM, Tannich E, Rothe C. Risk factors for and management of metronidazole-refractory giardiasis in international travellers: A retrospective analysis. Travel Med Infect Dis 2021;43:102090. [PMID: 34082086 DOI: 10.1016/j.tmaid.2021.102090] [Reference Citation Analysis]
24 Nolan MJ, Jex AR, Pangasa A, Young ND, Campbell AJ, Stevens M, Gasser RB. Analysis of nucleotide variation within the triose-phosphate isomerase gene of Giardia duodenalis from sheep and its zoonotic implications. Electrophoresis 2010;31:287-98. [DOI: 10.1002/elps.200900480] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
25 Escobedo AA, Ballesteros J, González-Fraile E, Almirall P. A meta-analysis of the efficacy of albendazole compared with tinidazole as treatments for Giardia infections in children. Acta Trop 2016;153:120-7. [PMID: 26476393 DOI: 10.1016/j.actatropica.2015.09.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
26 Lopez-Velez R, Batlle C, Jiménez C, Navarro M, Norman F, Perez-Molina J. Short course combination therapy for giardiasis after nitroimidazole failure. Am J Trop Med Hyg 2010;83:171-3. [PMID: 20595497 DOI: 10.4269/ajtmh.2010.09-0742] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
27 Ansell BR, McConville MJ, Baker L, Korhonen PK, Emery SJ, Svärd SG, Gasser RB, Jex AR. Divergent Transcriptional Responses to Physiological and Xenobiotic Stress in Giardia duodenalis. Antimicrob Agents Chemother 2016;60:6034-45. [PMID: 27458219 DOI: 10.1128/AAC.00977-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
28 Ierardi E, Losurdo G, Iannone A, Piscitelli D, Amoruso A, Barone M, Principi M, Pisani A, Di Leo A. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored? Ann Gastroenterol. 2017;30:380-392. [PMID: 28655974 DOI: 10.20524/aog.2017.0165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
29 Ordóñez-Mena JM, McCarthy ND, Fanshawe TR. Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials. J Antimicrob Chemother 2018;73:596-606. [PMID: 29186570 DOI: 10.1093/jac/dkx430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
30 Nguyen TKT, Kherouf H, Blanc-pattin V, Allais E, Chevalier Y, Richez A, Ramade C, Peyron F. Evaluation of an immunochromatographic assay: Giardia-Strip® (Coris BioConcept) for detection of Giardia intestinalis in human fecal specimens. Eur J Clin Microbiol Infect Dis 2012;31:623-5. [DOI: 10.1007/s10096-011-1332-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
31 Walker MM, Talley NJ. Clinical value of duodenal biopsies--beyond the diagnosis of coeliac disease. Pathol Res Pract 2011;207:538-44. [PMID: 21940106 DOI: 10.1016/j.prp.2011.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
32 Argüello-García R, Cruz-Soto M, González-Trejo R, Paz-Maldonado LM, Bazán-Tejeda ML, Mendoza-Hernández G, Ortega-Pierres G. An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front Microbiol 2015;6:286. [PMID: 25914688 DOI: 10.3389/fmicb.2015.00286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
33 Bénéré E, Van Assche T, Cos P, Maes L. Variation in growth and drug susceptibility among Giardia duodenalis assemblages A, B and E in axenic in vitro culture and in the gerbil model. Parasitology 2011;138:1354-61. [DOI: 10.1017/s0031182011001223] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
34 Argüello-García R, Leitsch D, Skinner-Adams T, Ortega-Pierres MG. Drug resistance in Giardia: Mechanisms and alternative treatments for Giardiasis. Adv Parasitol 2020;107:201-82. [PMID: 32122530 DOI: 10.1016/bs.apar.2019.11.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
35 Granados CE, Reveiz L, Uribe LG, Criollo CP. Drugs for treating giardiasis. Cochrane Database Syst Rev. 2012;12:CD007787. [PMID: 23235648 DOI: 10.1002/14651858.CD007787.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
36 Almirall P, Escobedo AA, Ayala I, Alfonso M, Salazar Y, Cañete R, Cimerman S, Galloso M, Olivero I, Robaina M, Tornés K. Mebendazole compared with secnidazole in the treatment of adult giardiasis: a randomised, no-inferiority, open clinical trial. J Parasitol Res 2011;2011:636857. [PMID: 22174992 DOI: 10.1155/2011/636857] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
37 Terra LL, Campanati L, De Souza W. Heterogeneity in the sensitivity of microtubules of Giardia lamblia to the herbicide oryzalin. Parasitol Res 2010;107:47-54. [DOI: 10.1007/s00436-010-1831-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Escobedo AA, Almirall P, Alfonso M, Salazar Y, Avila I, Cimerman S, Núñez FA, Dawkins IV. Hospitalization of Cuban children for giardiasis: a retrospective study in a paediatric hospital in Havana. Ann Trop Med Parasitol 2011;105:47-56. [PMID: 21294948 DOI: 10.1179/136485911X12899838413420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Escobedo AA, Almirall P, Alfonso M, Avila I, Cimerman S, Salazar Y, Dawkins IV, García RM. Caregiver perspectives for the prevention, diagnosis and treatment of childhood giardiasis in Havana City, Cuba. A qualitative study. Acta Trop 2011;119:99-106. [PMID: 21565150 DOI: 10.1016/j.actatropica.2011.04.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
40 Nabarro LE, Lever RA, Armstrong M, Chiodini PL. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013. Clin Microbiol Infect 2015;21:791-6. [PMID: 25975511 DOI: 10.1016/j.cmi.2015.04.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
41 Kolkhir P, Balakirski G, Merk HF, Olisova O, Maurer M. Chronic spontaneous urticaria and internal parasites--a systematic review. Allergy 2016;71:308-22. [PMID: 26648083 DOI: 10.1111/all.12818] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
42 Hounkong K, Sawangjaroen N, Kongyen W, Rukachaisirikul V, Wootipoom N. Mechanisms of 1-hydroxy-2-hydroxymethylanthraquinone from Coptosapelta flavescens as an anti-giardial activity. Acta Trop 2015;146:11-6. [PMID: 25735817 DOI: 10.1016/j.actatropica.2015.02.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Ortega-Pierres MG, Jex AR, Ansell BRE, Svärd SG. Recent advances in the genomic and molecular biology of Giardia. Acta Trop 2018;184:67-72. [PMID: 28888474 DOI: 10.1016/j.actatropica.2017.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
44 Speich B, Marti H, Ame SM, Ali SM, Bogoch II, Utzinger J, Albonico M, Keiser J. Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide. Parasit Vectors 2013;6:3. [PMID: 23289920 DOI: 10.1186/1756-3305-6-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
45 Wahab T, Ankarklev J, Lebbad M, Glavas S, Svärd S, Palm D. Real-time polymerase chain reaction followed by fast sequencing allows rapid genotyping of microbial pathogens. Scand J Infect Dis 2011;43:95-9. [PMID: 20950215 DOI: 10.3109/00365548.2010.524661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Espinosa Aranzales AF, Radon K, Froeschl G, Pinzón Rondón ÁM, Delius M. Prevalence and risk factors for intestinal parasitic infections in pregnant women residing in three districts of Bogotá, Colombia. BMC Public Health 2018;18:1071. [PMID: 30157817 DOI: 10.1186/s12889-018-5978-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
47 Escobedo AA, Almirall P, González-Fraile E, Ballesteros J. Efficacy of mebendazole in paediatric patients with giardiasis: A systematic review and meta-analysis. Acta Trop 2018;188:50-7. [PMID: 30092225 DOI: 10.1016/j.actatropica.2018.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Chen CZ, Kulakova L, Southall N, Marugan JJ, Galkin A, Austin CP, Herzberg O, Zheng W. High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements. Antimicrob Agents Chemother 2011;55:667-75. [PMID: 21078930 DOI: 10.1128/AAC.00618-10] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
49 Atabati H, Kassiri H, Shamloo E, Akbari M, Atamaleki A, Sahlabadi F, Linh NTT, Rostami A, Fakhri Y, Khaneghah AM. The association between the lack of safe drinking water and sanitation facilities with intestinal Entamoeba spp infection risk: A systematic review and meta-analysis. PLoS One 2020;15:e0237102. [PMID: 33147225 DOI: 10.1371/journal.pone.0237102] [Reference Citation Analysis]
50 Hart CJ, Munro T, Andrews KT, Ryan JH, Riches AG, Skinner-Adams TS. A novel in vitro image-based assay identifies new drug leads for giardiasis. Int J Parasitol Drugs Drug Resist 2017;7:83-9. [PMID: 28171818 DOI: 10.1016/j.ijpddr.2017.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chew TS, Hopper AD, Sanders DS. Is there a role for routine duodenal biopsy in diagnosing giardiasis in a European population? Scandinavian Journal of Gastroenterology 2009;43:1219-23. [DOI: 10.1080/00365520802101853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
52 Carter ER, Nabarro LE, Hedley L, Chiodini PL. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions. Clin Microbiol Infect 2018;24:37-42. [PMID: 28624613 DOI: 10.1016/j.cmi.2017.05.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
53 Boland-Nazar NS, Eslamirad Z, Sarmadian H, Ghasemikhah R. An In Vitro Evaluation of Ozonized Organic Extra-Virgin Olive Oil on Giardia Lamblia Cysts. Jundishapur J Microbiol 2016;9:e40839. [PMID: 28138377 DOI: 10.5812/jjm.40839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Ibrahim HS, Salem AI, Ahmed NMAE, El-Taweel HA. Pre-and post-treatment evaluation of intestinal inflammation in Giardia and Blastocystis infected children: a community-based study. J Parasit Dis 2021;45:1026-33. [PMID: 34789986 DOI: 10.1007/s12639-021-01398-7] [Reference Citation Analysis]
55 Schwartz CJ, Modi L, Simsir A, Sun W. Incidental giardiasis in a transduodenal fine-needle aspiration for suspected hilar liver mass. Diagn Cytopathol 2019;47:966-7. [PMID: 31045330 DOI: 10.1002/dc.24208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Sinha S, Prakash A, Sehgal R, Medhi B. Comparative effect of manuka honey on anaerobic parasitic protozoans with standard drug therapy under in vitro conditions: A preliminary study. Indian J Pharmacol 2018;50:197-203. [PMID: 30505056 DOI: 10.4103/ijp.IJP_227_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
57 Robertson LJ, Hanevik K, Escobedo AA, Mørch K, Langeland N. Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol 2010;26:75-82. [PMID: 20056486 DOI: 10.1016/j.pt.2009.11.010] [Cited by in Crossref: 128] [Cited by in F6Publishing: 115] [Article Influence: 10.7] [Reference Citation Analysis]
58 Leitsch D. Drug Resistance in the Microaerophilic Parasite Giardia lamblia. Curr Trop Med Rep 2015;2:128-35. [PMID: 26258002 DOI: 10.1007/s40475-015-0051-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 8.9] [Reference Citation Analysis]
59 Miyamoto Y, Eckmann L. Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia. Front Microbiol. 2015;6:1208. [PMID: 26635732 DOI: 10.3389/fmicb.2015.01208] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
60 Riches A, Hart CJS, Trenholme KR, Skinner-Adams TS. Anti-Giardia Drug Discovery: Current Status and Gut Feelings. J Med Chem 2020;63:13330-54. [PMID: 32869995 DOI: 10.1021/acs.jmedchem.0c00910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
61 Belo VS, Oliveira RBD, Fernandes PC, Nascimento BWL, Fernandes FV, Castro CLF, Santos WBD, Silva ESD. Fatores associados à ocorrência de parasitoses intestinais em uma população de crianças e adolescentes. Rev paul pediatr 2012;30:195-201. [DOI: 10.1590/s0103-05822012000200007] [Cited by in Crossref: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Ansell BR, McConville MJ, Ma'ayeh SY, Dagley MJ, Gasser RB, Svärd SG, Jex AR. Drug resistance in Giardia duodenalis. Biotechnol Adv 2015;33:888-901. [PMID: 25922317 DOI: 10.1016/j.biotechadv.2015.04.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
63 Tejman-Yarden N, Miyamoto Y, Leitsch D, Santini J, Debnath A, Gut J, McKerrow JH, Reed SL, Eckmann L. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother. 2013;57:2029-2035. [PMID: 23403423 DOI: 10.1128/aac.01675-12] [Cited by in Crossref: 97] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
64 Yu X, Abdullahi AY, Wu S, Pan W, Shi X, Hu W, Tan L, Li K, Wang Z, Li G. Prokaryotic Expression of α-13 Giardin Gene and Its Intracellular Localization in Giardia lamblia. Biomed Res Int 2017;2017:1603264. [PMID: 28286754 DOI: 10.1155/2017/1603264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
65 Shukla G, Kamboj S, Sharma B. Comparative Analysis of Antigiardial Potential of Heat Inactivated and Probiotic Protein of Probiotic Lactobacillus rhamnosus GG in Murine Giardiasis. Probiotics & Antimicro Prot 2020;12:271-9. [DOI: 10.1007/s12602-018-9506-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
66 Chandy E, Mccarthy J. Evidence behind the WHO Guidelines: Hospital Care for Children: What is the most appropriate treatment for giardiasis? Journal of Tropical Pediatrics 2007;55:5-7. [DOI: 10.1093/tropej/fmn073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
67 Palomo-Ligas L, Gutiérrez-Gutiérrez F, Ochoa-Maganda VY, Cortés-Zárate R, Charles-Niño CL, Castillo-Romero A. Identification of a novel potassium channel (GiK) as a potential drug target in Giardia lamblia: Computational descriptions of binding sites. PeerJ 2019;7:e6430. [PMID: 30834181 DOI: 10.7717/peerj.6430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Kim WJ, Korthals KA, Li S, Le C, Kalisiak J, Sharpless KB, Fokin VV, Miyamoto Y, Eckmann L. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia. Antimicrob Agents Chemother 2017;61:e02397-16. [PMID: 28396548 DOI: 10.1128/AAC.02397-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
69 Coulibaly JT, Ouattara M, D'Ambrosio MV, Fletcher DA, Keiser J, Utzinger J, N'Goran EK, Andrews JR, Bogoch II. Accuracy of Mobile Phone and Handheld Light Microscopy for the Diagnosis of Schistosomiasis and Intestinal Protozoa Infections in Côte d'Ivoire. PLoS Negl Trop Dis 2016;10:e0004768. [PMID: 27348755 DOI: 10.1371/journal.pntd.0004768] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
70 Coulibaly G, Ouattara M, Dongo K, Hürlimann E, Bassa FK, Koné N, Essé C, Yapi RB, Bonfoh B, Utzinger J, Raso G, N'Goran EK. Epidemiology of intestinal parasite infections in three departments of south-central Côte d'Ivoire before the implementation of a cluster-randomised trial. Parasite Epidemiol Control 2018;3:63-76. [PMID: 29774300 DOI: 10.1016/j.parepi.2018.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Strand E, Robertson L, Hanevik K, Alvsvåg J, Mørch K, Langeland N. Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. Clinical Microbiology and Infection 2008;14:1069-71. [DOI: 10.1111/j.1469-0691.2008.02078.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
72 Dashti N, Zarebavani M. Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1869-78. [PMID: 34324017 DOI: 10.1007/s00210-021-02124-z] [Reference Citation Analysis]
73 Escobedo AA, Lalle M, Hrastnik NI, Rodríguez-Morales AJ, Castro-Sánchez E, Cimerman S, Almirall P, Jones J. Combination therapy in the management of giardiasis: What laboratory and clinical studies tell us, so far. Acta Trop 2016;162:196-205. [PMID: 27349189 DOI: 10.1016/j.actatropica.2016.06.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
74 Tejman-Yarden N, Eckmann L. New approaches to the treatment of giardiasis. Curr Opin Infect Dis 2011;24:451-6. [PMID: 21857510 DOI: 10.1097/QCO.0b013e32834ad401] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
75 Tiash S, Saunders J, Hart CJS, Ryan JH, Riches AG, Skinner-Adams TS. An image-based Pathogen Box screen identifies new compounds with anti-Giardia activity and highlights the importance of assay choice in phenotypic drug discovery. Int J Parasitol Drugs Drug Resist 2020;12:60-7. [PMID: 32234669 DOI: 10.1016/j.ijpddr.2020.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
76 Payne PA, Artzer M. The Biology and Control of Giardia spp and Tritrichomonas foetus. Veterinary Clinics of North America: Small Animal Practice 2009;39:993-1007. [DOI: 10.1016/j.cvsm.2009.06.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
77 Granados CE, Reveiz L, Cuervo LG, Uribe LG, Criollo CP, Granados CE. Drugs for treating giardiasis. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007787] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
78 Perrucci S, Fichi G, Ricci E, Galosi L, Lalle M, Rossi G. In vitro and ex vivo evaluation of the anti-Giardia duodenalis activity of the supernatant of Slab51 (SivoMixx). PLoS One 2019;14:e0213385. [PMID: 30845190 DOI: 10.1371/journal.pone.0213385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]